Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...

“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...

The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a ...

These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...

A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals ...

People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...

Germany is widely recognized as one of the leading countries in the pharmaceutical industry boasting a rich history of innovation cutting-edge research and global influence With its well-established i ...

Investments in R&D and market expansion, particularly in emerging regions, will be crucial in shaping the future of the aspirin marketDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Aspirin Global ...

Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...

Borussia Dortmund - Bayer Leverkusen 2-3 highlights e gol: doppio Schick e Tella portano le Aspirine a -1 dalla vetta della ...

In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.